Immune parameters to consider when choosing T-Cell receptors for therapy

Burrows, Scott R. and Miles, John James 2013. Immune parameters to consider when choosing T-Cell receptors for therapy. Frontiers in Immunology 4 , 229. 10.3389/fimmu.2013.00229

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (486kB) | Preview

Abstract

T-cell receptor (TCR) therapy has arrived as a realistic treatment option for many human diseases. TCR gene therapy allows for the mass redirection of T-cells against a defined antigen while high affinity TCR engineering allows for the creation of a new class of soluble drugs. However, deciding which TCR blueprint to take forward for gene therapy or engineering is difficult. More than one quintillion TCR combinations can be generated by somatic recombination and we are only now beginning to appreciate that not all are functionally equal. TCRs can exhibit high or low degrees of HLA-restricted cross-reactivity and alloreact against one or a combination of HLA alleles. Identifying TCR candidates with high specificity and minimal cross-reactivity/alloreactivity footprints before engineering is obviously highly desirable. Here we will summarize what we currently know about TCR biology with regard to immunoengineering. © 2013 Burrows and Miles.

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	Frontiers Media S. A.
ISSN:	16643224
Date of First Compliant Deposit:	9 October 2018
Last Modified:	10 Jun 2023 22:46
URI:	https://orca.cardiff.ac.uk/id/eprint/94407

Citation Data

Cited 8 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item